Ethyl 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carboxylate, 98.0%, 1g

3-Amino-4-(methylamino)benzoic acid, 95.0%, 250mg

3-Bromo-5-chloropyridine-4-carboxaldehyde, 95%, 1g

3-(tert-Butyl)bicyclo[1.1.1]pentan-1-amine hydrochloride, 98%, 500mg

N-(tert-Butyl)-5-isobutylthiophene-2-sulfonamide, 95.0%, 250mg

N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide, 98%, 100mg

1,4-diethyl 2,5-dioxocyclohexane-1,4-dicarboxylate, 95%, 100g

(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methanol, 95.0%, 5g

Ethyl but-3-enoate (contains <30ppm MEHQ as inhibitor), 88.0%, 25g

3-(Oxan-4-yl)propan-1-amine, 95%, 1g

5-Bromo-benzo[b]thiophene, 99.00%, 25g

1-(4,5-Dihydro-1H-1,5-methanobenzo[d]azepin-3(2H)-yl)-2,2,2-trifluoroethanone, 95.0%, 25g

2-FLUORO-1-IODO-4-(TRIFLUOROMETHYL)BENZENE, 95%, 1g